Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives

Contraception

Volumn 59, Issue 4, 1999, Pages 237-243

  Van Heusden, A M ^a   Fauser, B C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Estradiol; Follicle development; Follicle stimulating hormone; Oral contraception; Ovarian activity; Pill free period

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ETHINYLESTRADIOL; FOLLITROPIN; GESTODENE; LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARY FUNCTION; VOLUNTEER;

BIOLOGY; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE METHODS; DESOGESTREL; ENDOCRINE SYSTEM; ETHINYL ESTRADIOL; FAMILY PLANNING; FOLLICLE STIMULATING HORMONE--ANALYSIS; GENITALIA; GENITALIA, FEMALE; GESTODENE; GONADOTROPINS; GONADOTROPINS, PITUITARY; HORMONES; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; ORAL CONTRACEPTIVES, LOW-DOSE; OVARIAN EFFECTS; OVARY; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; UROGENITAL SYSTEM;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; NORPREGNENES; OVARIAN FOLLICLE; OVARY; PITUITARY GLAND;

EID: 0032812416     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00025-6     Document Type: Article

References (18)

1. Kim Bjorklund T., Landgren B., Hamberger L. Is the contraceptive effect of 300 mcg of norethisterone mainly peripheral or central? Contraception. 45:1992;57-66.
2. Wan L.S., Ganguly M., Weiss G. Pituitary response to LHRH stimulation in women on oral contraceptives a follow-up dose response study . Contraception. 24:1981;229-234.
3. Rommler A., Baumgarten S., Schwartz U., Hammerstein J. Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release. Contraception. 25:1982;619-627.
4. Guillebaud J. The forgotten pill - and the paramount importance of the pill-free week. Br J Fam Plann. 12:1987;35-43.
5. Fauser B.C.J.M., van Heusden A.M. Manipulation of human ovarian function physiological concepts and clinical consequences . Endocrine Rev. 18:1997;71-106.
6. Pache T.D., Wladimiroff J.W., De Jong F.H., Hop W.C., Fauser B.C.J.M. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril. 54:1990;638-642.
7. van Santbrink E.J., Hop W.C., van Dessel H.J., De Jong F.H., Fauser B.C.J.M. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril. 64:1995;37-43.
8. van Dessel H.J., Schipper I., Pache T.D., Van Geldrop H., De Jong F.H., Fauser B. Normal human follicle development an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles . Clin Endocrinol. 44:1996;191-198.
9. Vallon A.M., Cristol P., Hedon B., et al. Ovarian suppressive activity of a low dose monophasic oral contraceptive during correct and incorrect pill intake. Contracept Fertil Sex. 20:1992;521-529.
10. Hedon B., Cristol P., Plauchut A., et al. Ovarian consequences of the transient interruption of combined oral contraceptives. Int J Fertil. 37:1992;270-276.
11. Landgren B., Csemiczky G. The effect of follicular growth and luteal function of 'missing the pill'. A comparison between a monophasic and a triphasic combined oral contraceptive. Contraception. 43:1991;149-159.
12. Killick S.R., Bancroft K., Oelbaum S., Morris J., Elstein M. Extending the duration of the pill-free interval during combined oral contraception. Adv Contracept. 6:1990;33-40.
13. Smith S.K., Kirkman R.J.E., Arce B.B., et al. The effect of deliberate omission of Trinordiol® or Microgynon® on the hypothalamo-pituitary-ovarian axis. Contraception. 34:1986;513-522.
14. Morris S.E., Groom G.V., Cameron E.D., Buckingham M.S., Everitt J.M., Elstein M. Studies on low-dose oral contraceptives plasma hormone changes in relation to deliberate pill (Microgynon 30) omission . Contraception. 20:1979;61-69.
15. Goldzieher J.W., de la Pena P.A., Chenault C.B., Cervantes A. Comparative studies of ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Am J Obstet Gynecol. 122:1975;625-636.
16. Groome N.P., Illingworth P.J., O'Brien M., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 81:1996;1401-1405.
17. Bazin B., Thevenot R., Bursaux C., Paris J. Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women. Br J Obstet Gynaecol. 94:1987;1199-1204.
18. Killick S.R. Ovarian follicles during oral contraceptive cycles their potential for ovulation . Fertil Steril. 52:1989;580-582.